Product image of Vyndaqel (Tafamidis Meglumine) supplied by GNH India

Vyndaqel

Active Ingredient:
Tafamidis Meglumine
Origin:
EU

Vyndaqel (Tafamidis Meglumine)

Vyndaqel (tafamidis meglumine) is an oral medication used to treat transthyretin amyloidosis. It helps stabilize transthyretin protein to slow disease progression. This overview covers key uses, effects, and safety notes for informed use.

Manufacturer / TM Owner

Pfizer Europe Ma Eeig

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

Indications & Clinical Uses

  • Vyndaqel is prescribed for adults with transthyretin amyloidosis, a rare condition where abnormal protein deposits damage organs and nerves. It is used to treat both symptomatic and asymptomatic forms of the disease. The medication works systemically to support protein stability, addressing the underlying cause of amyloid buildup. It is not a cure but may slow progression in affected individuals.

Side Effects

  • Vyndaqel is taken as a daily capsule, designed to be absorbed in the digestive tract for systemic circulation. Users may experience mild gastrointestinal effects such as nausea or diarrhea when starting treatment. These effects are generally temporary and resolve as the body adjusts. Regular monitoring by a healthcare provider is recommended to assess ongoing tolerance and effectiveness.

Precautions & Warnings

  • Vyndaqel should be stored at room temperature away from moisture and heat. It is important to take the medication exactly as prescribed and not to alter the dose without medical advice. Patients with liver problems or those taking certain other medications should inform their doctor before starting Vyndaqel. Pregnant or breastfeeding individuals should discuss risks with a healthcare provider.

Avoid Interactions

  • Vyndaqel may interact with medications that affect liver enzymes, such as CYP3A4 inhibitors or inducers, potentially altering its effectiveness. Alcohol use should be discussed with a doctor, as it may affect liver function or exacerbate side effects. Other drugs metabolized similarly may also interact; always inform your healthcare provider about all medications being taken.

Frequently Asked Questions

Vyndaqel is used to treat transthyretin amyloidosis in adults by stabilizing the transthyretin protein.

Vyndaqel is an oral capsule taken once daily with or without food, as directed by a healthcare provider.

Common side effects may include nausea, diarrhea, or abdominal discomfort, especially when starting treatment.

It may interact with certain drugs; consult your doctor before combining Vyndaqel with other medications.

Safety during pregnancy has not been established; discuss risks with your healthcare provider before use.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated:

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Tafamidis Meglumine

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT